Discrete Types of Osteoclast Precursors Can Be Generated from Embryonic Stem Cells

Stem Cells

Volumn 21, Issue 6, 2003, Pages 670-680

  Okuyama, Hiromi ^a,c   Tsuneto, Motokazu ^a   Yamane, Toshiyuki ^a,d   Yamazaki, Hidetoshi ^a,b   Hayashi, Shin Ichi ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c TAKARA BIO INC   (Japan)

^d STANFORD UNIVERSITY   (United States)

Author keywords

Clonal assays; Development; Embryonic stem cell; Experimental models; Hematopoiesis; In vitro culture; Mice; Osteoclast; Progenitor

Indexed keywords

BINDING FACTOR; CHIMERIC PROTEIN; FC RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 1 BINDING FACTOR;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL MATURATION; EMBRYO; EMBRYO CELL; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; STEM CELL;

ANIMALIA;

EID: 0142196780     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.21-6-670     Document Type: Article

References (41)

1. Suda T, Udagawa N, Takahashi N. Cells of bone: osteoclast generation. In: Bilezikian JP, Raisz LG, Roden GA, eds. Principles of Bone Biology. New York: Academic Press Inc., 1996:87-102.
2. Roodman GD. Cell biology of the osteoclast. Exp Hematol 1999;27:1229-1241.
3. Hayashi SI, Yamane T, Miyamoto A et al. Commitment and differentiation of stem cells to the osteoclast lineage. Biochem Cell Biol 1998;76:911-922.
4. Chambers TJ. Regulation of the differentiation and function of osteoclasts. J Pathol 2000;192:4-13.
5. Yamazaki H, Kunisada T, Yamane T et al. Presence of osteoclast precursors in colonies cloned in the presence of hematopoietic colony-stimulating factors. Exp Hematol 2001;29:68-76.
6. + dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes. Blood 1996;88:4029-4039.
7. Kurihara N, Suda T, Miura Y et al. Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood 1989;74:1295-1302.
8. Lee MY, Lottsfeldt JL, Fevold KL. Identification and characterization of osteoclast progenitors by clonal analysis of hematopoietic cells. Blood 1992;80:1710-1716.
9. Hayashi SI, Miyamoto A, Yamane T et al. Osteoclast precursors in bone marrow and peritoneal cavity. J Cell Physiol 1997;170:241-247.
10. Yoshida H, Hayashi SI, Kunisada T et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990;345:442-444.
11. Yasuda H, Shima N, Nakagawa N et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and identical to TRANCE/RAKL. Proc Natl Acad Sci USA 1998;95:3597-3602.
12. Lacey DL, Timms E, Tan HL et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-176.
13. Yamane T, Kunisada T, Yamazaki H et al. Development of osteoclasts from embryonic stem cells through a pathway that is c-fms but not c-kit dependent. Blood 1997;90:3516-3523.
14. Yamane T, Kunisada T, Yamazaki H et al. Sequential requirements for SCL/tal-1, GATA-2, macrophage colony-stimulating factor, and osteoclast differentiation factor/osteoprotegerin ligand in osteoclast development. Exp Hematol 2000;28:833-840.
15. Nakano T, Kodama H, Honjo T. Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 1994;265:1098-1101.
16. Carmeliet P, Ferreira V, Breier G et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996;380:435-439.
17. Ferrara N, Carver-Moore K, Chen H et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996;380:439-442.
18. Doetschman TC, Eistetter H, Katz M et al. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 1985;87:27-45.
19. Nishikawa SI, Ogawa M, Nishikawa S et al. B lymphopoiesis on stromal cell clone: stromal cell clones acting on different stages of B cell differentiation. Eur J Immunol 1988;18:1767-1771.
20. Kodama H, Nose M, Niida S et al. Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells. Exp Hematol 1994;22:979-984.
21. Yamane T, Kunisada T, Hayashi SI. Embryonic stem cells as a model for studying osteoclast lineage development. Methods Mol Biol 2002;185:97-106.
22. Tsuneto M, Yamane T, Okuyama H et al. In vitro differentiation of mouse ES cells into hematopoietic, endothelial, and osteoblastic cell lineages: a possibility of in vitro organogenesis. Methods Enzymol 2003;365:98-114.
23. Ogawa M, Matsuzaki Y, Nishikawa S et al. Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med 1991;174:63-71.
24. Shevde N, Anklesaria P, Greenberger JS et al. Stromal cell-mediated stimulation of osteoclastogenesis. Proc Soc Exp Biol Med 1994;205:306-315.
25. Neufeld G, Cohen T, Gengrinovitch S et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999;13:9-22.
26. Hemmi H, Okuyama H, Yamane T et al. Temporal and spatial localization of osteoclasts in colonies from embryonic stem cells. Biochem Biophys Res Commun 2001;280:526-534.
27. Okuyama H, Yamazaki H, Yamane T et al. Development of osteoclast lineage cells. Research Advances in Blood. (Global Research Network) 2001;1:75-84.
28. Galli SJ, Zsebo KM, Geissler EN. The kit ligand, stem cell factor. Adv Immunol 1994;55:1-96.
29. Russell ES. Hereditary anemias of the mouse: a review for geneticists. Adv Genet 1979;20:357-458.
30. Ogawa M, Nishikawa S, Yoshinaga K et al. Expression and function of c-Kit in fetal hemopoietic progenitor cells: transition from the early c-Kit-independent to the late c-Kit-dependent wave of hemopoiesis in the murine embryo. Development 1993;117:1089-1098.
31. de Vries C, Escobedo JA, Ueno H et al. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992;255:989-991.
32. Terman BI, Dougher-Vermazen M, Carrion ME et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992;187:1579-1586.
33. Soker S, Takashima S, Miao HQ et al. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998;92:735-745.
34. Fong GH, Rossant J, Gertsenstein M et al. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995;376:66-70.
35. Barleon B, Sozzani S, Zhou D et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996;87:3336-3343.
36. Sawano A, Iwai S, Sakurai Y et al. Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 2001;97:785-791.
37. Shalaby F, Rossant J, Yamaguchi TP et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995;376:62-66.
38. 188. Nat Med 1999;5:495-502.
39. Yamada Y, Takakura N, Yasue H et al. Exogenous clustered neuropilin 1 enhances vasculogenesis and angiogenesis. Blood 2001;97:1671-1678.
40. Carmeliet P, Collen D. Vascular development and disorders: molecular analysis and pathogenic insights. Kidney Int 1998;53:1519-1549.
41. Aase K, Lymboussaki A, Kaipainen A et al. Localization of VEGF-B in the mouse embryo suggests a paracrine role of the growth factor in the developing vasculature. Dev Dyn 1999;215:12-25.